Skip to main content

Bacterial Polysaccharides and Their Research Innovations

 Bacteria are covered by polysaccharides at the outer surface in the form of capsules, glycoproteins, or glycolipids. Such a bacterial sugar coat constitutes the principal antigens in most pathogenic bacteria and plays an important role in host-pathogen interactions. With more understanding of polysaccharide biosynthesis and its interplay with polymer modification and synthesis, scientists have recognized the research potential of polysaccharides in developing novel antibacterial strategies and novel applications like epidemiological markers.

 

Bacterial polysaccharides mainly are carbohydrates like capsular polysaccharides (CPS) and lipopolysaccharides (LPS). Capsular polysaccharides are highly-hydrated homo- or hetero-polymers that are composed of repeating sugar units joined by glycosidic linkages. They usually are inserted into the cell surface of bacteria by covalent attachments to either phospholipid or lipid-A molecules. Lipopolysaccharide, on the contrary, is a membrane component characteristic of Gram-negative bacteria consisting of lipid A, core-oligosaccharide, and O-polysaccharide (or O-antigen) joined by a covalent bond. With a series of advanced technologies, including chemical degradation techniques, nuclear magnetic resonance spectroscopy, and mass spectrometry techniques, researchers now can comprehensively carry out structural characterization and analysis of bacterial polysaccharides and understand their functions.

 

CPS usually constitutes the outermost layer of the cell and gets involved in mediating interactions between bacteria and the environment, for which polysaccharide capsules are implied as important virulence factors for several bacterial pathogens. Moreover, CPS can protect bacteria from phagocytosis if the pathogen is attacked by innate immune responses. Capsular polysaccharides prevent the activation of phagocytosis by decreasing antibody opsonization and masking ligands for phagocytic cell attachment. Therefore, polysaccharides antibodies as biomarkers have become the research hotspot in the field of disease diagnosis and treatment. Researchers at the Queensland University of Technology have successfully characterized the genomic loci in Acinetobacter baumannii that are responsible for cell-surface polysaccharide synthesis and have proven them to be effective epidemiological markers to track A. baumannii.

 

Lipopolysaccharides are large molecules localized in the outer layer of the bacterial membrane and populate much of the cell surface. LPS can establish a permeability barrier, protecting bacteria from toxic molecules such as antibiotics and bile salts. In addition to being a key component of the cell envelope, LPS also contributes to host-pathogen interactions with the innate immune system. Bacterial adaptive changes, including modulation of LPS synthesis during chronic infection, could protect disease by preventing phagocytosis and adhesion to epithelial cells with O-antigen lipopolysaccharide or enhancing host immune response evasion with a production of less immunogenic lipid A, etc. In some cases, the immune response against the bacterial polysaccharide could be too dramatic to be toxic to the host, which confers protection against the disease in some depth.

 

Polysaccharides could also be found in fungi and yeast in the form of glucans, chitin, and mannans, playing a major role in the cell wall structure. Current research on fungal polysaccharides mainly aims at identifying influential factors for their biological activity and elucidating their interactive role in various chemical medicine. The biological activities of fungal polysaccharides are shown to influence anti-tumor, anti-microbial, immune-stimulation or immunomodulatory activity, nutritional component, and hypoglycemic activity.

 

With more understanding of the structure of various polysaccharides, details about the mechanism of action of polysaccharides in different systems are being revealed. Polysaccharides of bacteria and fungi will share more extensive applications in diagnostics and therapeutics.

Labels:

Comments

Post a Comment

Popular posts from this blog

How Haptens Differ from Antigens and Become Immunogens?

The  difference between antigens vs. haptens  is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.   What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.   What are Antigens? Antigen s, including proteins, peptides, and polysaccharides, are immunogen   molecules  that can trigger immune response s or naturally bind to   immune   components . An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibod...
Post a Comment
Read more

Review: Creative Biolabs' Model-org Antibodies Fluorescently Labeling Services

Model organisms (Model-org) are non-human species, from which researchers can get insights into other organisms in biological research processes. Various model organism species such as zebrafish, flies, yeast, and rice, greatly contribute to the basic and clinical research in animal husbandry, fishery ， agriculture, forestry, etc.   Investigations on model organisms can be aided by antibody labeling when samples of interest need to be detected, isolated, or purified, though the selection of a proper label can be a challenge.   To select the best antibody labeling way for our Model-org project, we then found Creative Biolabs, one of the most well-established CROs for antibody development. After a comprehensive discussion and consultancy with the scientists at Creative Biolabs, fluorescent tags were  suggested based on our research direction. Fluorescent labels are directly conjugated to the antibody of interest, indicating that we can directly detect the number of fluoresc...
Post a Comment
Read more

Metagenomics Enhances Infectious Disease Surveillance

  Infectious lower respiratory diseases and diarrheal diseases are the leading causes of death globally . And the ongoing COVID-19 pandemic, which has contributed to 4.1 million deaths in 2019, once again is reminding the necessity of proactively identifying early signs of infectious disease outbreaks before things are getting worse. Conventional microbial diagnostics techniques would identify pathogens under specific culture conditions by serological detection of pathogen-associated antibodies or microbial genetic investigation using PCR, but these methods have been seen obvious shortcomings in pathogen coverage. It's highly required to find advanced scientific tools that are more sensitive even with a low microbial load or when targeted microorganisms are not suitable for  in vitro  culture, for which metagenomic approaches that can profile all DNA or RNA of a patient sample are increasingly catching the eyes of researchers.   How metagenomics can be used in infect...
Post a Comment
Read more